25 May 2013
Keywords: tranzyme, pharma, closes, new, 20m, financing, company
Article | 12 November 2007
Tranzyme Pharma, a US company developing small-molecule drugs for the treatment of gastrointestinal and metabolic diseases, has completed a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 November 2007
5 November 2007
24 May 2013
© 2013 thepharmaletter.com